Adelphi Real World

Adelphi Real World are proud to share a recent publication in Advance in Therapy 'Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States'. Patrick Connor Johnson, Abigail Bailey, Qiufei Ma, Neil Milloy, Emilia Biondi, Ruben G. W. Quek, Sarah Weatherby & Sophie Barlow https://lnkd.in/gwRg92AJ Using data from the Adelphi Follicular Lymphoma Disease Specific Programme™. To learn more please contact Andrea Cochrane or Neil Milloy #FL #DSP #RWE #RWD

Adelphi Real World are proud to share a new publication using data from the DLBCL Disease Specific Programme published in Frontiers in Oncology. Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey. Johnson PC, Bailey A, Ma Q, Milloy N, Butcher J, Sanderson I, Weatherby S, Meadows R and Quek RGW (2024). https://lnkd.in/evu2nD9F To learn more about this research or our DLBCL programme, please reach out to Jake Butcher or Andrea Cochrane (andrea.cochrane@adelphigroup.com) #DLBCL #RWE #RWD #DSP #ONCOLOGY https://lnkd.in/eKdbgaYd

The British Association of Dermatology Annual Meeting takes place 2-4 July in Manchester. A few miles down the road from our Global Headquarters Jenny Austin and Simran M. will be there in person and would welcome the opportunity to meet with existing and new clients. We have a wide range of Dermatology Disease Specific Programmes available. To learn more please contact Andrea Cochrane (andrea.cochrane@adelphigroup.com) or Andy Collicott (andy.collicott@adelphigroup.com) #BAD2024 #DSP #Dermatology #RWE #RWD https://lnkd.in/e2xyVDDB https://lnkd.in/ePSq36zA https://lnkd.in/gTfXWnwN

Is attending 10th Congress of the European Academy of Neurology in Helsinki part of your plans? Jonathan de Courcy and Jack Wright will be there in person from 29th June to 2nd July and would welcome the opportunity to meet. We have poster presentations and e-posters being presented utilising DSP data from Duchenne muscular dystrophy, Chronic Inflammatory Demyelinating Polyneuropathy and Migraine programmes. To arrange a meeting or learn more contact Andrea Cochrane (andrea.cochrane@adelphigroup.com) https://lnkd.in/e2xyVDDB https://lnkd.in/ePSq36zA #EAN24 #Neurology #DSP #RWE #RWD

Are you planning on attending IFPA Conference - 7th World Psoriasis & Psoriatic Arthritis Conference - 27-29 June 2024, Stockholm, Sweden?   Nicola Massey (Booth) and Megan Hughes would welcome the opportunity to meet with you.   To learn more about our Disease Specific Programmes - new data in house for Psoriatic Arthritis and currently in data collection for Psoriasis - or arrange a meeting at IFPA please contact Andrea Cochrane (andrea.cochrane@adelphigroup.com) #IFPAConference2024 #DSP #RWE #RWD

#ADA2024 starts today - James Jackson and Steven Lobosco will be onsite. To learn more about our new wave of Diabetes Disease Specific Programmes or our range of CVRM-L programmes please reach out directly or contact Andrea Cochrane (andrea.cochrane@adelphigroup.com) https://lnkd.in/gUnsUgpc #RWE #RWD #DSP

Adelphi Real World is proud to share a new publication "Improving Assessment of Adherence Behaviors and Drivers: Targeted Literature Review and Concept Elicitation Interviews in Multiple Countries and Disease Populations" Bentley S, Exall E, Morgan L, Roche N, Khunti K, Rossom R, Piercy J, Arbuckle R, Higgins VS. Patient Prefer Adherence. 2024;18:1231-1242 Medication adherence is crucial for achieving clinical goals and is often sub-optimal in a real-world patient setting. This qualitative research highlights variations in medication non-adherence, and the different forms and drivers of nonadherence, based on individuals’ demographic and clinical characteristics. The conceptual model developed advances previous models of medication adherence and may support healthcare professionals in the management of patients and how they can be supported to take medication as intended. The research ultimately informed the development of the Adelphi Adherence Questionnaire (ADAQ©), a novel patient-reported outcome measure that can be used across health conditions. For further information on using ADAQ, please contact Andrea Cochrane (andrea.cochrane@adelphigroup.com) https://lnkd.in/eEMrG5Ds

Adelphi Real World are proud to share a new publication using data from the Adelphi Real World IBD Disease Specific Programme published in IBD Journal. Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey, Inflammatory Bowel Diseases, 2024. Johan Burisch, Ailsa Hart, Andreas Sturm, Christine Rudolph, Rachael Meadows, Anna Jus, Fatima Dawod, Haridarshan Patel, Alessandro Armuzzi, ; izae119, https://lnkd.in/ee8_4GMa To learn more about this research or our IBD programme, please reach out to Fatima Dawod or Andrea Cochrane (andrea.cochrane@adelphigroup.com) #RWE #RWD #DSP #IBD

Attending American Diabetes Association 84th Scientific Sessions - June 21-24, 2024 - Orlando? James Jackson and Steven Lobosco will be on site and happy to meet to discuss our range of Adelphi Disease Specific Programmes. If you would like to meet up, please reach out directly or contact Andrea Cochrane (andrea.cochrane@adelphigroup.com) #RWE #RWD #DSP #ADA2024

Is EHA 2024 on your agenda? Our specialist teams will be represented at the conference and would welcome the opportunity to meet with you. To arrange a meeting please reach out to the teams attending Amanda Ribbands (née Heselwood), Katie Lewis, Emily Luke, Susanna Libby and Tom Bailey or email Andrea Cochrane directly to organise a meeting (andrea.cochrane@adelphigroup.com) #RWE #RWD #DSP #EHA2024 https://lnkd.in/e2xyVDDB https://lnkd.in/e_vN5JC2 https://lnkd.in/eKdbgaYd https://lnkd.in/ejycuk2j https://lnkd.in/gynHNAcN